Search Results for: stem cell clinics

Initial reactions to RFK Jr. being HHS Secretary

RFK Jr.

There were many reasons for the U.S. Senate not to confirm RFK Jr. as HHS Secretary. Reasons that transcended politics. Nonetheless, Senate Republicans confirmed him today for that post. Some of them had voiced serious concerns before including one physician Senator, Dr. Bill Cassidy, but they all voted for Kennedy anyway. All except Mitch McConnell, […]

Initial reactions to RFK Jr. being HHS Secretary Read More »

FDA letters to Chara Biologics & Evolutionary Biologics continue its unprecedented slew of warnings

Dr. Joy Kong, Chara Biologics, Chara Health

What is Chara Biologics? Why did the FDA just warn them and another firm? FDA’s CBER keeps up fast pace of warnings Before we get into that, the FDA biologics branch, CBER, has more generally kept up an unprecedented pace of warning letters over the past 13 months. I wrote late last year how 2024

FDA letters to Chara Biologics & Evolutionary Biologics continue its unprecedented slew of warnings Read More »

Weekly reads: FDA modernization, TFs on the brain, mortality timer, pluripotent trials

FDA

How will things change at the FDA under the second Trump Administration? It’s a key question for our field but not easy to answer. Most likely there will be more instability at the agency. Some leaders, like of CDER, have already left. in my overall regenerative medicine predictions for 2025, I’ve included more predictions about

Weekly reads: FDA modernization, TFs on the brain, mortality timer, pluripotent trials Read More »

2025 PRP fact-check and review: cost and possible benefits

PRP-Platelet-Rich-Plasma-being-injected-into-a-hand

Platelet-rich plasma or PRP has become one of the most commonly used regenerative products at unproven clinics. The orthopedics departments at many universities are now offering PRP as well. What is behind this trend? How much data are there to back up all this enthusiasm for platelet-rich plasma? The goal of this post is to

2025 PRP fact-check and review: cost and possible benefits Read More »

Weekly reads: hit pause on human life, CIRM pause, 23andMe data, blast from the past

Remember cryonics, the idea that you could hit pause on human life? This relies on the super-cold power of liquid nitrogen or some other ultra-freezing method. Apparently cryonics is still a thing and there are people with even just their heads frozen. A new story claims a different way to hit the pause button on

Weekly reads: hit pause on human life, CIRM pause, 23andMe data, blast from the past Read More »

Big spike in FDA warning letters to unproven biologics firms

Dr. Peter Marks, Director of CBER, FDA warning

This year already appears to be a record one for cell and tissue therapy-related warning letters the FDA. Directly or indirectly, these come from the FDA’s Center for Biologics Evaluation and Research or CBER. Something unusual seems to be happening. FDA’s CBER has been exceptionally active in 2024 including on cell & tissue products I’ve

Big spike in FDA warning letters to unproven biologics firms Read More »

Stanford’s Mike Snyder and wellness coach Tony Robbins together yield some puzzling research

Mike Snyder and Tony Robbins, Stanford Tony Robbins

What do you think of when I  mention Stanford professor Mike Snyder and self-help guru Tony Robbins together? I would not necessarily have imagined them forming a connection but science is full of surprises. I’ve admired Snyder’s work in genetics for a long time. I’m most familiar these days with Robbins for his interest in

Stanford’s Mike Snyder and wellness coach Tony Robbins together yield some puzzling research Read More »

Another state challenges FDA on biologics as Nevada OKs risky, unproven oligo, gene, & other therapies

Julie Pazina, Nevada law biologics

Nevada has a relatively new 2023 law legalizing non-FDA-approved biological and gene therapies. I use the word “therapies” here loosely.  They are not scientifically or medically proven to work or be safe so they could lead to substantial harm. This is yet another early step in a likely growing trend of states challenging FDA authority

Another state challenges FDA on biologics as Nevada OKs risky, unproven oligo, gene, & other therapies Read More »

Recommended reads: MSC analysis points to challenges, IPSC NKs kill liver cancer, turning white fat into brown

MSC single cell transcriptome, MSC

Mesenchymal stromal/stem cells or MSCs are widely used by unproven clinics, but MSC research also suggests real promise in specific areas. Clinics mainly use adipose MSCs (often called SVF) or bone marrow MSCs. However, umbilical cord MSC preparations are getting more popular too. Many questions swirl around the use of MSCs including what exactly are

Recommended reads: MSC analysis points to challenges, IPSC NKs kill liver cancer, turning white fat into brown Read More »